Clinical Trials at the Cancer Institute of New Jersey – Hamilton
Currently recruiting participants (updated as of May 28, 2015)
Lung Cancer
CINJ 031105
ECOG E2511
Breast Cancer
SWOG S1007
SWOG S1207
NSABP B-55
Gynecologic
CINJ 130909
Colon
CALGB C80702
Prostate
SWOG S1216
Modulation of autophagy with hydroxychloroquine in patients with
advanced/recurrent non-small cell lung cancer - a Phase II study.
Phase I and Randomized Phase II Double Blind Clinical Trial of Cisplatin and
Etoposide in Combination with Veliparib (ABT- 888) or Placebo as Frontline
Therapy for Extensive Stage Small Cell Lung Cancer: Phase II
A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine
Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone
Receptor-Positive and HER2-Negative Breast Cancer with Recurrence Score
(RS) of 25 or Less
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of
Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients with HighRisk, Hormone Receptor-Positive and HER2/neu Negative Breast Cancer
A Randomised, Double-Blind, Parallel Group, Placebo-Controlled Multi-Centre
Phase III Study to Assess the Efficacy and Safety of Olaparib Versus Placebo as
Adjuvant Treatment in Patients with Germline BRCA1/2 Mutations and High
Risk HER2 Negative Primary Breast Cancer Who Have Completed Definitive
Local Treatment and Neoadjuvant or Adjuvant Chemotherapy
Psychological Interventions for Gynecologic Cancer
A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus
Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer
A Phase III Randomized Trial Comparing Androgen Deprivation Therapy
+TAK-700 with Androgen Deprivation Therapy + Bicalutamide in Patients with
Newly Diagnosed Metastatic Hormone Sensitive Prostrate Cancer
Cancer Patients and Care givers
The Cancer
A survey for patients and care givers to share their story, that can help bring
Experience Registry knowledge and insights about their social and emotional needs and provide them
Trial
with information on the development of new programs, research and policy.
Adult Patients undergoing a Nipple Sparing Mastectomy
ASBrS Nipple
The American Society of Breast Surgeons would like to use your health
Sparing Mastectomy information in a Nipple Sparing Mastectomy Registry. This information may
Registry
include data that identifies you. By placing the health information of many
patients such as you into a research registry, researchers will be able to increase
their knowledge about breast cancer. It is anticipated that the Registry will assist
our investigators by allowing researchers to review and study the medical
records of many individuals to answer questions about breast cancer and its
treatment.
Multiple Myeloma
Randomized Phase III Trial of Bortezomib, LENalidomide and Dexamethasone (VRd)
Versus Carfilzomib, Lenalidomide and Dexamethasone (CRd) Followed by Limited or
Indefinite DURation Lenalidomide MaintenANCE in Patients with Newly Diagnosed
Symptomatic Multiple Myeloma (ENDURANCE)
Chronic Lymphocytic Leukemia (CLL)
A Randomized Phase III Study of Bendamustine Plus Rituximab Versus Ibrutinib Plus
A041202
Rituximab Versus Ibrutinib Alone in Untreated Older Patients (>= 65 Years of Age)
With Chronic Lymphocytic Leukemia (CLL)
E1A11
For more information, please contact the Research Office at 609-631-6946